These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Postoperative infections: the use of thymostimulin (TP1) in patients at risk]. Lai N; Lavosi V; Pinna S; Salis G; Colombo E; Vargiu P G Chir; 1992; 13(6-7):377-8. PubMed ID: 1389989 [TBL] [Abstract][Full Text] [Related]
3. Thymostimulin prophylaxis of postoperative infections in anergic patients. Farina EC; Garino M; Balbo G Can J Surg; 1986 Nov; 29(6):445-6. PubMed ID: 3536050 [TBL] [Abstract][Full Text] [Related]
4. Peripheral blood lymphocyte changes after benign gastrointestinal surgery. Role of thymostimulin in reversing the postoperative immunodepression seen in humans. Garcia-Valdecasas JC; Martinez A; Lopoez-Boado MA; de Lacy AM; Cugat E; Grande L; Fuster J; Visa J; Pera C Hepatogastroenterology; 1988 Oct; 35(5):219-22. PubMed ID: 2976389 [TBL] [Abstract][Full Text] [Related]
5. [Prevention of infection and improvement of cenesthesia with thymostimulin during chemotherapy following mastectomy]. Alba E; Visentin L; Farina C; Wierdis T Minerva Ginecol; 1991 Dec; 43(12):585-7. PubMed ID: 1819777 [TBL] [Abstract][Full Text] [Related]
6. Thymostimulin in the antiinfectious treatment in patients with burns. Schiavon M; Chiarelli A; Löhr G; Mazzoleni F Arzneimittelforschung; 1987 May; 37(5):557-60. PubMed ID: 3497638 [TBL] [Abstract][Full Text] [Related]
7. Thymostimulin effect on the immune response in neoplastic patients submitted to surgical treatment. Cangemi V; Volpino P; D'Andrea N; Gentili S; Fabrizi S; Ippoliti F; Piat G Panminerva Med; 1993 Dec; 35(4):218-23. PubMed ID: 8202335 [TBL] [Abstract][Full Text] [Related]
8. Use of a thymic factor in the prevention of postoperative infections. Terrizzi A; Gipponi M; Meloni C; Farina PG; Pellas C; Berti Riboli E Ital J Surg Sci; 1985; 15(3):243-8. PubMed ID: 4066275 [TBL] [Abstract][Full Text] [Related]
17. Immunoprophylaxis with thymostimulin in oncological surgery. Russello D; Puleo S; Succi L; Di Cataldo A; Scuideri M; Scilletta B; Di Blasi M; Guastella T; Latteri F J Chemother; 1989 Jul; 1(4 Suppl):1307-8. PubMed ID: 16312878 [No Abstract] [Full Text] [Related]
18. [Efficacy of immunomodulating treatment in patients with different degrees of immunosuppression]. Manfè AZ; Grigoletto R; De Silvestro G; Bernante P; Faccioli AM Minerva Chir; 1991 May; 46(10):511-5. PubMed ID: 1922868 [TBL] [Abstract][Full Text] [Related]
19. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. Markewitz A; Faist E; Lang S; Endres S; Fuchs D; Reichart B J Thorac Cardiovasc Surg; 1993 Jan; 105(1):15-24. PubMed ID: 8419695 [TBL] [Abstract][Full Text] [Related]
20. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients]. Ianiushina VV Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]